There is an increased risk of death for some people taking antidepressants or anti-anxiety medications, a new study from Queen’s University Belfast has suggested. The study led by researchers from the ...
Add Yahoo as a preferred source to see more of our stories on Google. An estimated quarter of traditional Medicare beneficiaries with dementia are prescribed risky, brain-altering drugs despite years ...
A massive UK study of more than 165,000 dementia patients has uncovered troubling new evidence about risperidone, a commonly ...
Hope for Alzheimer's prevention emerges as scientists find existing seizure drug may stop disease progression if taken ...
Neuroscientists at King's College London have pinpointed a mechanism behind the increased neural connectivity observed in the ...
What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...
A drug that curbs delusions in Parkinson's patients did the same for people with Alzheimer's and other forms of dementia. That's the result of a study in which the benefit was so clear, the trial was ...
Lykke Vestergaard Kastbjerg, 42, and her father Niels, 73, are among hundreds travelling to the UK for treatment.
There’s rarely good news about Alzheimer’s disease, but a failed study may open the door to more research about vascular dementia. Novo Nordisk NVO announced Monday that its oral GLP-1 called Rybelsus ...
Medications commonly used to treat dementia could result in harmful weight loss, according to UC San Francisco researchers, and clinicians need to account for this risk when prescribing these drugs to ...
Health: Experts Warn These Early Dementia Signs Often Get Missed — But Early Detection Makes A Big Difference The specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results